Does Dupilumab Improve Sinonasal Outcomes in AERD Patients? April 8, 2026 Despite limited randomized trials specific to AERD, the consistent improvements in sinonasal outcomes across studies strongly support dupilumab as an effective treatment for AERD patients post-FESS.